Navigation Links
G-CON Manufacturing, Inc. Announces Maik Jornitz as President
Date:7/29/2014

Bryan, TX (PRWEB) July 29, 2014

G-CON Manufacturing Inc., the standard in design and production of autonomous modular cleanrooms, today announced a new leadership appointment designed to drive the company’s ambitious growth initiatives in the United States and abroad.

Maik Jornitz, Chief Operating Officer of G-Con Manufacturing, has been named as the company’s President charged with leading the pioneering company through its next phase of market growth.

“As we enter this stage of development and look forward to providing our next generation of products, having an experienced and forward thinking leader, like Maik, in this position is invaluable to our organization," said David Shanahan, Chief Executive Officer and Chairman of G-Con’s Board of Directors.

Jornitz joined G-CON in September 2012 as Vice President of Business Development. He was promoted to Chief Operating Officer in March 2013. Before joining G-CON, Jornitz was a Senior Vice President at Sartorius Stedim where he managed their global bioprocess product management and marketing. His career at Sartorius spanned 25 years.

Jornitz received a Masters of Engineering in Bioengineering at the University of Applied Sciences in Hamburg, Germany and successfully completed the PED program at IMD Business School in Lausanne, Switzerland.

In making the announcement, Shanahan further stated, “Since Maik joined G-CON Manufacturing, he has advanced our business into multiple target markets and broadened both the reach and quality of our products. His knowledge and experience within the biopharmaceutical industry has been invaluable. He is a proven leader with an exceptional track record and we are thrilled to have him in this position.”

About G-Con Manufacturing

G-CON was founded to address the fact that existing systems and methodologies for constructing biomanufacturing and personalized medicine suites were neither affordable nor flexible enough to meet the rapidly changing market's needs. G-CON's founders have significant experience in designing, building, operating, and maintaining a variety of traditional biomanufacturing facilities. They are familiar with the excessive cost to build, lack of flexibility, and high expense to maintain these traditional facilities and have leveraged this experience to create the G-CON POD™ solution. Moreover, the G-CON team understands that future facility designs must be multipurpose and repurposable, instead of fixed and specialized with ineffective capacity utilization.

For more information about G-Con, please visit the Company's website at http://www.gconbio.com.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12051552.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. GEA Process Engineering and G-CON Manufacturing Announce PCMM Collaboration with Pfizer
2. New 2 Hour Educational Learning Labs at MD&M West Will Feature Baxter Bioscience, BMW, Dell, GE Healthcare, Mattel, Northrup Grumman, Starbucks and Other Leading Groups in Design, Manufacturing, Engineering and Automation
3. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
4. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at ReportsnReports.com
5. PI Ofers 6-Axis Nanopositioning Stage for Nano-Manufacturing, Microscopy, Nanomanipulation
6. Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products
7. International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio
8. Sapphire Energy Announces New CEO James Levine
9. WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?”
10. JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort
11. Texas Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):